News

Publish Date
As Senate’s gaze lands on patents, a former US PTO chief calls the effort a ‘broad misunderstanding’
Former USPTO Officials Urge Vidal to Immediately Withdraw NPRM on Terminal Disclaimers
Ex-USPTO Directors Want Vidal To Withdraw Disclaimer Plans
Quintet of Ex-Patent Office Officials Slam Proposed Rulemaking
C4IP Urges Senate Judiciary to Ignore Common Myths About Drug Patents
Group chaired by former USPTO directors questions office’s AI guidance over ‘human contribution’
Industry Reacts to USPTO Guidance on Using AI to Innovate
USPTO Guidance On AI And Patents Draws Worry And Praise
IP Owners Call For PTAB Amendment Plan To Be Permanent
Celebrating World IP Day: Is the Innovative Future Sustainable?
AI Copyright Bill Thrills Artists. Developers Call It Unworkable
The Bayh-Dole Act and the Debate Over “Reasonable Price” March-In Rights
Scroll to Top